Role of Methylglyoxal in Diabetic Cardiovascular and Kidney Diseases: Insights from Basic Science for Application into Clinical Practice.
CONCLUSION: Reducing MG levels directly using scavengers or indirectly via activation of Nrf2/Glo1 may serve as a novel and potent therapeutic strategy to counter the deleterious effects of MG in diabetic complications.
PMID: 30179128 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Sankaralingam S, Ahmed A, Rahman M, Eid AH, Munusamy S Tags: Curr Pharm Des Source Type: research
More News: Acetylcysteine | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Fortamet | Heart | Metformin | Science | Urology & Nephrology